SEC 13F Intelligence

Waddell & Reed Financial Inc / VRTX

Waddell & Reed Financial Inc’s Vertex Pharmaceuticals Inc Position

Does Waddell & Reed Financial Inc own Vertex Pharmaceuticals Inc (VRTX)? Yes — 1.40M shares worth $300M (+0.62% of its 13F portfolio) as of Q1 2021, up from 1.40M shares the prior filed quarter.

Position Value
$300M
Q1 2021
Shares
1.40M
% of Portfolio
+0.62%
Quarters Held
10
currently held

Position History VRTX

Reported value by quarter
Q4 ’18: $360MQ4 ’18Q1 ’19: $386MQ2 ’19: $410MQ2 ’19Q3 ’19: $379MQ4 ’19: $505MQ4 ’19Q1 ’20: $491MQ2 ’20: $510MQ2 ’20Q3 ’20: $474MQ4 ’20: $330MQ4 ’20Q1 ’21: $300Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20211.40M$300M+0.62%
Q4 20201.40M$330M+0.70%
Q3 20201.74M$474M+1.14%
Q2 20201.76M$510M+1.32%
Q1 20202.06M$491M+1.60%
Q4 20192.31M$505M+1.25%
Q3 20192.24M$379M+0.98%
Q2 20192.23M$410M+1.01%
Q1 20192.10M$386M+0.96%
Q4 20182.17M$360M+1.02%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Waddell & Reed Financial Inc’s full portfolio or all institutional holders of VRTX.